본문 바로가기
KERD
논문KCI 등재

Independent Predictors for Primary Non-Function after Liver Transplantation

Shawn J. Pelletier|오창권|Robert G. Sawyer|Timothy L. Pruett|Hilary A. Sanfey
연세대학교의과대학 (Yonsei University College of Medicine)|2004.12|Yonsei Medical Journal|제45권 제6호|pp. 1155-1161

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류의학일반

초록

Abstract

Primary non-function (PNF) after liver transplantation has been found to be the most common cause of early graft loss, which accounts for up to 36% of such failures. The cause of PNF is not known. The purpose of this study was to identify factors associated with and independently predictive of PNF after liver transplantation. Four hundreds twenty-four liver transplants performed at the Charles O. Strickler Transplant Center, University of Virginia were retrospectively reviewed. PNF was defined as the failure of an allograft after revascularization with no discernable cause, leading either to retransplantation or to patient death. Risk factors were analyzed using the Pearson chi-square test for univariate analysis and logistic regression for multivariate analysis. Factors found to be associated with PNF included: female recipient (6.4% vs. 2.6%, p=0.045), African-American donor (9.5% vs. 3.2%, p=0.043), inter-racial donor to recipient transplantation (9.5% vs. 2.8%, p=0.008), severe encephalopathy pretransplant (11.1% vs. 3.1%, p=0.034), pretransplant recipient PTT >50 seconds (10.9% vs. 2.8%, p=0.004), portal vein reconstruction with conduit (15.0% vs. 3.5%, p=0.011), and downsizing of graft (22.9% vs. 3.8%, p=0.007). Logistic regression identified the use of donor iliac vein conduit for the portal vein reconstruction (p=0.003, odds ratio=3.15, 95% confidence interval: 1.49-6.64) and the racial difference between donor and recipient (p=0.012, odds ratio=2.31, 95% confidence interval: 1.20- 4.45) to be independent predictors of PNF. The exact cause of these findings, whether physiologic or immunologic, remains unknown. If confirmed in larger data sets, the attention to these factors may minimize the possibility of PNF in non- emergency situations.

참고문헌 (49)

  1. "Hepatic retransplantation", 17, pp.264~271 (1985)
  2. "Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survival", 21, pp.2385~2388 (1989)
  3. "Retransplantation of the liver: a seven-year experience", 55, pp.1083~1087 (1993)
  4. "Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation", 23, pp.2263~2265 (1991)
  5. "Cause and timing of first allograft failure in orthotopic liver transplantation: a study of 177 consecutive patients", 14, pp.1054~1062 (1991)
  6. "Graft failure: cause, recognition, and treatment. In: Busuttil RW, Klintmalm GB, editors. Transplantation of the liver", pp.607~ (1996), Philadelphia: Saunders
  7. "Donor data in liver grafts with primary non-function- a preliminary analysis by the European Liver Registry", 21, pp.2383~2384 (1989)
  8. "Analysis of donor and recipient variables and early graft function after orthotopic liver transplantation", 21, pp.3355~ (1989)
  9. "Primary nonfunction of the liver graft: when should we retransplant?", 23, pp.1954~ (1991)
  10. "The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation", 51, pp.157~163 (1991)
  11. "Primary nonfunction: is there a contribution from the back table bath?", 49, pp.739~743 (1991)
  12. "One thousand liver transplants: the lessons learned", 219, pp.490~499 (1994)
  13. "Prostaglandin E1 for primary nonfunction following liver transplantation", 21, pp.3360~3361 (1989)
  14. "Treatment of primary liver graft nonfunction with prostaglandin E1", 48, pp.447~453 (1989)
  15. "Primary graft nonfunction following orthotopic liver transplantation: treatment with prostacyclin", 24, pp.2693~2695 (1992)
  16. "Successful reversal of primary graft non-function in a liver transplant patient treated with prostaglandin E1", 62, pp.314~316 (1992)
  17. "Improved results with retransplantation of the liver", 21, pp.2407~2408 (1989)
  18. "Risk factors for primary dysfunction after liver transplantation-a multivariate analysis", 55, pp.807~813 (1993)
  19. "Safe use of hepatic allograft from donors older than 70 years", 62, pp.62~65 (1996)
  20. "The use of older donor livers for hepatic transplantation", 49, pp.377~381 (1990)
  21. "The use of "marginal" donors for organ transplantation: influence of donor age on outcome", 51, pp.135~141 (1991)
  22. "The use of marginal donors for liver transplantation: a retrospective study of 365 liver donors", 53, pp.383~386 (1992)
  23. "Analysis of donor criteria for the prediction of outcome in clinical liver transplantation", 19, pp.2378~2382 (1987)
  24. "Experience with human liver grafts obtained after donor cardiac standstill", 19, pp.3862~3863 (1987)
  25. "Primary nonfunction of hepatic allografts with preexisting fatty infiltration", 47, pp.903~905 (1989)
  26. "The outcome of steatotic grafts in liver transplantation", 23, pp.1538~1540 (1991)
  27. "A rat fatty liver transplant model", 55, pp.737~741 (1993)
  28. "Lipopeliosis: fat induced sinusoidal dilatation in transplanted liver mimicking peliosis hepatis", 45, pp.1109~1110 (1992)
  29. "The effects of cold preservation on steatotic graft viability in rat liver transplantation", 56, pp.282~287 (1993)
  30. "The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation", 23, pp.1536~1537 (1991)
  31. "Current status of organ preservation with Univeristy of Wisconsin solution", 115, pp.306~310 (1991)
  32. "Extended preservation of human grafts with UW solution", 261, pp.711~714 (1989)
  33. "Effect on cold ischemic time on the early outcome of human hepatic allografts preserved with UW solution", 51, pp.1000~1004 (1991)
  34. "Principles of solid-organ preservation by cold storage", 45, pp.673~676 (1988)
  35. "The effects of fasting on the quality of liver preservation by simple cold storage", 50, pp.943~948 (1990)
  36. "Correlation of donor nutritional status with sinusoidal lining cell viability and liver function in the rat", 51, pp.1176~1183 (1991)
  37. "Livers from fasted rats acquire resistance to warm and cold ischemia injury", 55, pp.728~732 (1993)
  38. "Endogenous endotoxemia during orthotopic liver transplantation in dogs", 21, pp.3861~3862 (1989)
  39. "Endotoxemia and human liver transplantation", 21, pp.3833~3841 (1989)
  40. "Nitric oxide mediates lipopolysaccharide-induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver", 18, pp.380~388 (1993)
  41. "Preservation and reperfusion injuries in liver allografts: an overview and synthesis of current studies", 53, pp.957~978 (1992)
  42. "Cyclosporine hepatotoxicity and cold ischemia liver damage", 24, pp.1984~ (1992)
  43. "Liver rejection and its differentiation from other causes of graft dysfunction", 5, pp.369~374 (1985)
  44. "Primary dysfunction after liver transplantation: donor or recipient fault?", pp.434~436
  45. "Effect of race upon organ donation and recipient survival in liver transplantation", 35, pp.1391~1396 (1990)
  46. "Race is not a critical factor in orthotopic liver transplantation", 29, pp.3729~3730 (1997)
  47. "Ethnic variation in patient and graft survival after liver transplantation: identification of a new risk factor for chronic allograft rejection", 56, pp.1381~1384 (1993)
  48. "Liver transplantation in patients with thrombosis of the portal, splenic or superior mesenteric vein", 80, pp.81~85 (1993)
  49. "Complications of venous reconstruction in human orthotopic liver transplantation", 205, pp.404~414 (1987)

관련 논문AI추천

Biliary Complications after Living Donor Liver Transplantation Differ from Those after Deceased Donor Liver TransplantationJang Sung Ill, Lee Dong Ki거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제2호Diagnostic Performance of a Comprehensive Risk Model for Posthepatectomy Liver FailureChung Yong Eun거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제2호The impact of ischemia-free liver transplantation on improving the prognosis of recipients using functionally marginal liver grafts: Editorial on “Ischemia-free liver transplantation improves the prognosis of recipients using functionally marginal liver grafts”Ho Joong Choi대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Clinical implication of hepatic volumetry for living donor liver transplantation정우경대한간학회 · Clinical and Molecular Hepatology2018 · 제24권 제1호＂Small-for-size Graft＂ and ＂Small-for-size Syndrome＂ in Living Donor Liver TransplantationKoicho Tanaka, Yasuhiro Ogura연세대학교의과대학 · Yonsei Medical Journal2004 · 제45권 제6호How to optimize the outcome of liver transplantation for non-alcoholic fatty liver diseaseByeong Geun Song, Dong Hyun Sinn대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호

이 간행물의 다른 논문 (17건)

Landmarks in Clinical Transplantation in Korea김유선, 조원현pp. 963-967Regulatory T Cells - An Emerging Role in TransplantationGang Feng, Kathryn Woodpp. 968-977T Cell-specific Immunosuppression Using Tautomycetin or PTD-conjugated Protein Drugs최제민, 양정진, 이상규, 채욱진pp. 978-990Chronic Cyclosporine Nephrotoxicity: New Insights and Preventive Strategices양철우, Can Li, 임선우, 선보경pp. 1004-1016The Past, Present, and Future of Xenotransplantation김재영, 이병천, 강성근, 이정렬, 황우석, 안규리pp. 1017-1024
원문 보기